Literature DB >> 20523258

Ocular ischemia and ischemic oculomotor nerve palsy after vascular embolization of injectable calcium hydroxylapatite filler.

Mi Sun Sung1, Hyeong Gyun Kim, Kyung In Woo, Yoon-Duck Kim.   

Abstract

A healthy 25-year-old man who received a calcium hydroxylapatite filler injection for nose augmentation by a dermatologist suddenly developed blepharoptosis and orbital pain on the right side, associated with progressive visual disturbance of the right eye. Patchy necrosis at the nose and glabella, limitations of extraocular movements, and anterior segment ischemia, as evidenced by conjunctival injection, chemosis, corneal edema, dilated pupil, hyphema, and hypopyon, were noted. Orbital CT demonstrated linear deposits of a similar density to bone in the right medial orbit and eyelid, suggestive of multiple emboli along the conjunctival vessels. A provisional diagnosis of ocular ischemia and ischemic oculomotor nerve palsy secondary to vascular embolization was made. After 3 months, visual acuity, all intraocular inflammation, oculomotor nerve palsy, and skin necrosis resolved completely except for a dilated pupil.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20523258     DOI: 10.1097/IOP.0b013e3181bd4341

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  13 in total

1.  In vitro and in vivo radiosensitization induced by hydroxyapatite nanoparticles.

Authors:  Sheng-Hua Chu; Surya Karri; Yan-Bin Ma; Dong-Fu Feng; Zhi-Qiang Li
Journal:  Neuro Oncol       Date:  2013-03-21       Impact factor: 12.300

2.  Cerebral Angiographic Findings of Cosmetic Facial Filler-related Ophthalmic and Retinal Artery Occlusion.

Authors:  Yong-Kyu Kim; Cheolkyu Jung; Se Joon Woo; Kyu Hyung Park
Journal:  J Korean Med Sci       Date:  2015-11-30       Impact factor: 2.153

3.  Problems associated with alloplastic materials in rhinoplasty.

Authors:  Hyun-Soo Kim; Su-Sung Park; Myung-Hoon Kim; Min-Su Kim; Seok-Kwun Kim; Keun-Cheol Lee
Journal:  Yonsei Med J       Date:  2014-11       Impact factor: 2.759

4.  Ophthalmic Artery Occlusion and Subsequent Retinal Fibrosis From a Calcium Hydroxylapatite Filler Injection.

Authors:  Daniel J Oh; Yi Jiang; William F Mieler
Journal:  J Vitreoretin Dis       Date:  2019-04-26

5.  Partial vision recovery after iatrogenic retinal artery occlusion.

Authors:  Shu-Fang Hsiao; Yi-Hsun Huang
Journal:  BMC Ophthalmol       Date:  2014-10-11       Impact factor: 2.209

6.  Choroid vascular occlusion and ischemic optic neuropathy after facial calcium hydroxyapatite injection- a case report.

Authors:  Chien-Chih Chou; Hsin-Han Chen; Yi-Yu Tsai; You-Ling Li; Hui-Ju Lin
Journal:  BMC Surg       Date:  2015-03-08       Impact factor: 2.102

7.  "Walk the Rim, Feel the Bone" Technique in Superior Sulcus Filling.

Authors:  Audrey L G Looi; Kai-Ling Yong
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-01-07

8.  A case report of ophthalmic artery emboli secondary to Calcium Hydroxylapatite filler injection for nose augmentation- long-term outcome.

Authors:  Eyal Cohen; Yossi Yatziv; Igal Leibovitch; Anat Kesler; Ran Ben Cnaan; Ainat Klein; Dafna Goldenberg; Zohar Habot-Wilner
Journal:  BMC Ophthalmol       Date:  2016-07-08       Impact factor: 2.209

9.  Isolated Ophthalmoplegia Following Filler Injections to the Upper Face.

Authors:  Elaine M Downie; Yanjun Chen; Mark J Lucarelli; Cat N Burkat
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2020 Nov/Dec       Impact factor: 1.746

10.  Hydroxyapatite nanoparticles inhibit the growth of human glioma cells in vitro and in vivo.

Authors:  Sheng-Hua Chu; Dong-Fu Feng; Yan-Bin Ma; Zhi-Qiang Li
Journal:  Int J Nanomedicine       Date:  2012-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.